Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Filings indexed 1,643 across all filing types
Latest filing 2009-09-10 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, dates of transactions, and nature of the trades. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is about 3100 characters, which is consistent with a detailed notice of director share transactions rather than a full financial report or announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2009-09-10 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Daily share buy-back notice' and references Appendix 3E, which is a standard form for reporting on-market share buy-back activities to the ASX. It contains details about the number of shares bought back, total consideration paid, participation by directors, and compliance statements. The document length is 2263 characters, which is relatively short and focused solely on buy-back activity. There is no financial statement or comprehensive report content, only a regulatory notice about share repurchase activity. Therefore, this document fits the category of 'Transaction in Own Shares' (POS).
2009-09-09 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Daily share buy-back notice' and references Appendix 3E, which is a standard form used for reporting share buy-back activities to the ASX (Australian Securities Exchange). It details the number of shares bought back, total consideration paid, and compliance statements related to the buy-back. The document is short (2191 characters) and focuses solely on reporting the share repurchase activity without any broader financial data or analysis. This matches the description of a 'Transaction in Own Shares' filing, which reports company buy-back or sale of its own shares. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-09-07 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Daily share buy-back notice' and references Appendix 3E, which is a regulatory form related to share repurchase activities. It provides detailed information about the number of shares bought back, total consideration paid, participation by directors, and compliance statements. The document is relatively short (2213 characters) and focuses solely on the buy-back activity without containing comprehensive financial statements or broader financial performance data. This matches the description of a 'Transaction in Own Shares' filing, which reports on the company's share repurchase activities. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2009-09-06 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, highest and lowest prices paid, and compliance statements. The document is short (2241 characters) and is a regulatory notice about share repurchase activity rather than a full financial report or announcement of a new report. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-09-03 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market buy-back activity. It provides details about shares bought back, total consideration paid, and compliance statements. It is a regulatory notice about the company's share repurchase activity rather than a full financial report or earnings release. The document length is short (2262 characters) and it is a specific announcement about share buy-back activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS).
2009-08-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.